Huimin Geng
Huimin Geng
Assistant Adjunct Professor, UCSF
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy
WWL Choi, DD Weisenburger, TC Greiner, MA Piris, AH Banham, ...
Clinical cancer research 15 (17), 5494-5502, 2009
7292009
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
J Iqbal, DD Weisenburger, TC Greiner, JM Vose, T McKeithan, C Kucuk, ...
Blood 115 (5), 1026-1036, 2010
3462010
EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis
I Velichutina, R Shaknovich, H Geng, NA Johnson, RD Gascoyne, ...
Blood, The Journal of the American Society of Hematology 116 (24), 5247-5255, 2010
2902010
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition
C Duy, C Hurtz, S Shojaee, L Cerchietti, H Geng, S Swaminathan, ...
Nature 473 (7347), 384-388, 2011
1912011
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies
J Iqbal, C Kucuk, RJ Deleeuw, G Srivastava, W Tam, H Geng, D Klinkebiel, ...
Leukemia 23 (6), 1139-1151, 2009
1862009
TET1 is a tumor suppressor of hematopoietic malignancy
L Cimmino, MM Dawlaty, D Ndiaye-Lobry, YS Yap, S Bakogianni, Y Yu, ...
Nature immunology 16 (6), 653-662, 2015
1592015
Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia
S Swaminathan, L Klemm, E Park, E Papaemmanuil, A Ford, SM Kweon, ...
Nature immunology 16 (7), 766-774, 2015
1462015
CREBBP inactivation promotes the development of HDAC3-dependent lymphomas
Y Jiang, A Ortega-Molina, H Geng, HY Ying, K Hatzi, S Parsa, D McNally, ...
Cancer discovery 7 (1), 38-53, 2017
1362017
DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma
R Shaknovich, H Geng, NA Johnson, L Tsikitas, L Cerchietti, JM Greally, ...
Blood, The Journal of the American Society of Hematology 116 (20), e81-e89, 2010
1362010
RUNX1 is a key target in t (4; 11) leukemias that contributes to gene activation through an AF4-MLL complex interaction
AC Wilkinson, E Ballabio, H Geng, P North, M Tapia, J Kerry, D Biswas, ...
Cell reports 3 (1), 116-127, 2013
1192013
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile
K Cramer-Morales, M Nieborowska-Skorska, K Scheibner, M Padget, ...
Blood, The Journal of the American Society of Hematology 122 (7), 1293-1304, 2013
1162013
Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity
S De, R Shaknovich, M Riester, O Elemento, H Geng, M Kormaksson, ...
PLoS Genet 9 (1), e1003137, 2013
1132013
Metabolic gatekeeper function of B-lymphoid transcription factors
LN Chan, Z Chen, D Braas, JW Lee, G Xiao, H Geng, KN Cosgun, C Hurtz, ...
Nature 542 (7642), 479-483, 2017
1122017
Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways
K Dybkaer, J Iqbal, G Zhou, H Geng, L Xiao, A Schmitz, F d'Amore, ...
BMC genomics 8 (1), 1-17, 2007
1022007
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia
Z Chen, S Shojaee, M Buchner, H Geng, JW Lee, L Klemm, B Titz, ...
Nature 521 (7552), 357-361, 2015
1002015
Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy
YT Hsieh, EJ Gang, H Geng, E Park, S Huantes, D Chudziak, K Dauber, ...
Blood, The Journal of the American Society of Hematology 121 (10), 1814-1818, 2013
952013
Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia
H Geng, C Hurtz, KB Lenz, Z Chen, D Baumjohann, S Thompson, ...
Cancer cell 27 (3), 409-425, 2015
892015
MLL-rearranged acute lymphoblastic leukemias activate BCL-2 through H3K79 methylation and are sensitive to the BCL-2-specific antagonist ABT-199
JM Benito, L Godfrey, K Kojima, L Hogdal, M Wunderlich, H Geng, I Marzo, ...
Cell reports 13 (12), 2715-2727, 2015
882015
BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint
S Swaminathan, C Huang, H Geng, Z Chen, R Harvey, H Kang, C Ng, ...
Nature medicine 19 (8), 1014-1022, 2013
882013
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma
MG Cardenas, W Yu, W Beguelin, MR Teater, H Geng, RL Goldstein, ...
The Journal of clinical investigation 126 (9), 3351-3362, 2016
842016
The system can't perform the operation now. Try again later.
Articles 1–20